Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Peeper

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Cell|June 17, 2008
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory networkThomas Kuilman, Chrysiis Michaloglou, Liesbeth C W Vredeveld, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Genome Research|September 17, 2017
Massive reshaping of genome-nuclear lamina interactions during oncogene-induced senescenceChristelle Lenain, Carolyn A de Graaf, Ludo Pagie, et al.
Molecular Cancer Therapeutics|July 5, 2019
<i>In Vivo</i> ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in MelanomaIleine M Sanchez, Timothy J Purwin, Inna Chervoneva, et al.
European Journal of Immunology|February 14, 2023
Acidity-mediated induction of FoxP3<sup>+</sup> regulatory T cellsDisha Rao, Johanna A Stunnenberg, Ruben Lacroix, et al.
Molecular Systems Biology|December 25, 2014
ROCK1 is a potential combinatorial drug target for BRAF mutant melanomaMarjon A Smit, Gianluca Maddalo, Kylie Greig, et al.
Journal of Proteome Research|May 27, 2015
Signal Transduction Reaction Monitoring Deciphers Site-Specific PI3K-mTOR/MAPK Pathway Dynamics in Oncogene-Induced SenescenceErik L de Graaf, Joanna Kaplon, Shabaz Mohammed, et al.
Pharmacological Research|May 25, 2025
Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibitionDanielle G Carvalho, Juliana C N Kenski, Daniel A Moreira, et al.
Nature|October 5, 2017
Cancer drug addiction is relayed by an ERK2-dependent phenotype switchXiangjun Kong, Thomas Kuilman, Aida Shahrabi, et al.
Nature|May 21, 2013
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescenceJoanna Kaplon, Liang Zheng, Katrin Meissl, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Cell|June 17, 2008
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory networkThomas Kuilman, Chrysiis Michaloglou, Liesbeth C W Vredeveld, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Genome Research|September 17, 2017
Massive reshaping of genome-nuclear lamina interactions during oncogene-induced senescenceChristelle Lenain, Carolyn A de Graaf, Ludo Pagie, et al.
Molecular Cancer Therapeutics|July 5, 2019
<i>In Vivo</i> ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in MelanomaIleine M Sanchez, Timothy J Purwin, Inna Chervoneva, et al.
European Journal of Immunology|February 14, 2023
Acidity-mediated induction of FoxP3<sup>+</sup> regulatory T cellsDisha Rao, Johanna A Stunnenberg, Ruben Lacroix, et al.
Molecular Systems Biology|December 25, 2014
ROCK1 is a potential combinatorial drug target for BRAF mutant melanomaMarjon A Smit, Gianluca Maddalo, Kylie Greig, et al.
Journal of Proteome Research|May 27, 2015
Signal Transduction Reaction Monitoring Deciphers Site-Specific PI3K-mTOR/MAPK Pathway Dynamics in Oncogene-Induced SenescenceErik L de Graaf, Joanna Kaplon, Shabaz Mohammed, et al.
Pharmacological Research|May 25, 2025
Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibitionDanielle G Carvalho, Juliana C N Kenski, Daniel A Moreira, et al.
Nature|October 5, 2017
Cancer drug addiction is relayed by an ERK2-dependent phenotype switchXiangjun Kong, Thomas Kuilman, Aida Shahrabi, et al.
Nature|May 21, 2013
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescenceJoanna Kaplon, Liang Zheng, Katrin Meissl, et al.
Pageof 12